Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06177483 · ClinicalTrials.gov registry record · NA
Bioavailability Evaluation of CurQ+ Curcumin Formulation
A NA study, sponsored by ESM Technologies.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06177483 is a NA study that has completed, run by ESM Technologies. The registered enrollment target is 20 participants.
The verdict
NCT06177483, a NA study, has completed, sponsored by ESM Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men \& women.
Interventions
- DIETARY_SUPPLEMENT 95% curcumin extract powder
- DIETARY_SUPPLEMENT curQ+ curcumin formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06177483
The ClinicalTrials.gov registry entry for NCT06177483 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ESM Technologies, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 95% curcumin extract powder is the first listed.
NCT06177483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06177483 about?
NCT06177483 is a clinical study titled "Bioavailability Evaluation of CurQ+ Curcumin Formulation". This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men \& women.
What is the current status of trial NCT06177483?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-01. Estimated completion is 2024-09-10.
What interventions are being tested in trial NCT06177483?
The interventions under investigation include: 95% curcumin extract powder (DIETARY_SUPPLEMENT), curQ+ curcumin formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06177483?
This trial is sponsored by ESM Technologies, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.